All Stories

  1. Rationale and Design of the ACS-BP Study: Prognostic Value of In-Hospital Blood Pressure and Indices of Atherosclerosis in Acute Coronary Syndromes

    Article • Current Vascular Pharmacology, August 2020, Bentham Science Publishers

    Alexandros Kasiakogias, Kyriakos Dimitriadis, Ioannis Leontsinis, CHRISTOS FRAGOULIS, Konstantinos Konstantinou, Elias Tolis

  2. Microvascular Complications of Type 2 Diabetes Mellitus

    Article • Current Vascular Pharmacology, January 2020, Bentham Science Publishers

    Kyriakos Dimitriadis

  3. SPRINT trial phenotypes and cardiovascular risk: The ‘Marathon’ of data analysis is still on

    Article • European Journal of Preventive Cardiology, August 2019, SAGE Publications

    Kyriakos Dimitriadis

  4. Future Anti-aldosterone Agents

    Article • Current Pharmaceutical Design, April 2019, Bentham Science Publishers

    Kyriakos Dimitriadis, Alexandros Kasiakogias, Panayiotis Iliakis, Ioannis Andrikou, Ioannis Leontsinis

  5. Aortic Stenosis, Aortic Regurgitation and Arterial Hypertension

    Article • Current Vascular Pharmacology, January 2019, Bentham Science Publishers

    Kyriakos Dimitriadis, Dr Konstantinos Toutouzas

  6. Role of PCSK9 Inhibitors in High Risk Patients with Dyslipidemia: Focus on Familial Hypercholesterolemia

    Article • Current Pharmaceutical Design, January 2019, Bentham Science Publishers

    Kyriakos Dimitriadis

  7. Renal resistive index in hypertensive patients

    Article • Journal of Clinical Hypertension, October 2018, Wiley

    Kyriakos Dimitriadis, Ioannis Andrikou

  8. Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease

    Article • Cardiovascular & Haematological Disorders - Drug Targets, June 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Kyriakos Dimitriadis

  9. Sodium-glucose Cotransporter 2 Inhibitors: Impact on Body Weight and Blood Pressure Compared with other Antidiabetic Drugs

    Article • Cardiovascular & Haematological Disorders - Drug Targets, June 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Kyriakos Dimitriadis

  10. Clinical Value of Measuring the Renin/Aldosterone Levels: Optimising the Management of Uncontrolled/Resistant Hypertension

    Article • Current Vascular Pharmacology, December 2017, Bentham Science Publishers

    Kyriakos Dimitriadis

  11. Renal Denervation Therapy: Can it Contribute to Better Blood Pressure Control in Hypertension?

    Article • Current Vascular Pharmacology, December 2017, Bentham Science Publishers

    Kyriakos Dimitriadis

  12. Modern management of hypertensive emergencies and urgencies: Do we need more technology, paramedics, or physicians?

    Article • Journal of Clinical Hypertension, July 2017, Wiley

    Kyriakos Dimitriadis